APA (7th ed.) Citation

T, S., R, S., S, S., X, O., ST, T., H, M., . . . P, T. (2026). Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy. Gut, 75(4), 733. https://doi.org/10.1136/gutjnl-2024-334667

Chicago Style (17th ed.) Citation

T, Sheng, et al. "Spatial Profiling of Patient-matched HER2 Positive Gastric Cancer Reveals Resistance Mechanisms to Targeted Therapy." Gut 75, no. 4 (2026): 733. https://doi.org/10.1136/gutjnl-2024-334667.

MLA (9th ed.) Citation

T, Sheng, et al. "Spatial Profiling of Patient-matched HER2 Positive Gastric Cancer Reveals Resistance Mechanisms to Targeted Therapy." Gut, vol. 75, no. 4, 2026, p. 733, https://doi.org/10.1136/gutjnl-2024-334667.